Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
freem
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Openai/6966e871-a3c0-8012-ad81-1877ae7fcbdb
Add languages
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Special pages
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{DISPLAYTITLE:BCG Vaccine and T1D}} ''This conversation was exported from ChatGPT''<ref>{{cite web|title=BCG Vaccine and T1D|url=https://chatgpt.com/share/6966e871-a3c0-8012-ad81-1877ae7fcbdb|publisher=ChatGPT|access-date=2026-01-15}}</ref> == gpt-5-2 == === User: summarize this study === summarize this study === Assistant: Here’s a clear, plain-English summary of the study, with the key takeaways and why it matters: === Here’s a clear, plain-English summary of the study, with the key takeaways and why it matters: ==== Summary of the Study ==== What was studied This study investigated how the Bacillus Calmette-Guérin (BCG) vaccine lowers blood sugar in people with long-standing type 1 diabetes (T1D)—despite the absence of insulin production. Specifically, the researchers wanted to identify which organ(s) are responsible for the increased glucose uptake seen after BCG treatment bcg-T1D-spleen-study . ==== Study Design ==== * Human trial: - 6 adults with long-standing T1D received repeated BCG vaccinations over 2 years. - Researchers used ¹⁸F-FDG PET/CT scans to track glucose uptake in different organs before and after BCG. - Blood sugar control was monitored using HbA1c, and insulin production was checked via C-peptide. * Mouse experiments: - Mice were injected with BCG and sacrificed at intervals up to 20 weeks. - Organs were cultured to see where live BCG bacteria persisted. ==== Key Findings ==== ===== 1. BCG significantly lowers blood sugar — without restoring insulin ===== * HbA1c dropped by ~10% over time, reaching near-normal levels. * C-peptide remained near zero, confirming the effect was not due to insulin recovery bcg-T1D-spleen-study . ===== 2. BCG shifts immune cells to high-glucose consumption ===== * BCG reprograms immune cells (monocytes, T cells, lymphocytes) to favor aerobic glycolysis (the “Warburg effect”). * This causes immune cells to pull more glucose out of the bloodstream. ===== 3. The spleen is the dominant organ driving glucose uptake ===== * Among all organs studied (spleen, liver, bone marrow, lungs, muscle, brain): - Only the spleen showed a sustained, statistically significant increase in glucose uptake - The spleen’s glucose uptake increased by ~47% over two years bcg-T1D-spleen-study . ===== 4. Mouse data confirm the spleen as the key BCG niche ===== * Live BCG bacteria were found: - Persistently in the spleen (up to 20 weeks) - Transiently in bone marrow and liver - Rarely in lungs or muscle * The organ distribution of live BCG in mice closely matched the glucose-uptake patterns seen in humans. ==== Why This Matters ==== * The spleen is one of the largest immune organs in the body, packed with glucose-hungry lymphocytes. * Once reprogrammed by BCG, the spleen becomes a major systemic glucose sink, helping normalize blood sugar even without a functioning pancreas. * This helps explain how BCG can improve glycemic control in T1D—something previously difficult to justify based on blood immune cells alone. ==== Big Picture Conclusion ==== : BCG transforms the spleen into a new regulator of blood glucose. The study provides strong evidence that: * The immune system—specifically the spleen—can meaningfully regulate blood sugar * BCG’s long-term metabolic effects are driven by immune-cell reprogramming, not insulin * This mechanism may have implications beyond type 1 diabetes, including other autoimmune or metabolic diseases bcg-T1D-spleen-study . If you want, I can also: * Give a 1-paragraph layperson version * Break down strengths vs limitations * Explain why this study is controversial * Compare this to standard diabetes treatments == References == <references /> [[Category:ChatGPT Shares]] [[Category:openai]]
Summary:
Please note that all contributions to freem are considered to be released under the Creative Commons Attribution-ShareAlike 4.0 (see
Freem:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Cite web
(
edit
)
Module:Citation/CS1
(
edit
)
Module:Citation/CS1/COinS
(
edit
)
Module:Citation/CS1/Configuration
(
edit
)
Module:Citation/CS1/Date validation
(
edit
)
Module:Citation/CS1/Identifiers
(
edit
)
Module:Citation/CS1/Utilities
(
edit
)
Module:Citation/CS1/Whitelist
(
edit
)
Module:Citation/CS1/styles.css
(
edit
)